RHUMBLINE ADVISERS

Position in TAK — Takeda Pharmaceutical Co Ltd

CIK 1115418 BOSTON, MA

Position in TAK

as of Mar 31, 2026 · filed May 12, 2026 Compact

Position Value

$2,253,161

+$419,216 QoQ

Shares Held

121,661

+3.4% QoQ

Ownership

0.004%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Sep 2020

14 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

RHUMBLINE ADVISERS holds $438,094,582 across 50 Drug Manufacturers - Specialty & Generic names. TAK ranks #22 (0.5% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ZTS	Zoetis Inc.	1,229,009	$145,281,153
2	UTHR	UNITED THERAPEUTICS Corp	122,486	$72,631,748
3	NBIX	Neurocrine Biosciences Inc	303,820	$40,025,246
4	ELAN	Elanco Animal Health Inc	1,268,203	$30,348,097
5	VTRS	Viatris Inc	1,941,082	$26,224,017
6	ALKS	Alkermes plc.	449,531	$15,895,416
7	LNTH	Lantheus Holdings, Inc.	194,563	$14,757,603
8	HIMS	Hims & Hers Health, Inc.	643,856	$13,366,450

14 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$2,253,161	121,661	+3.4%	Shares	Sole	2026-05-12
2025-12-31	$1,833,945	117,636	+95.5%	Shares	Sole	2026-02-13
2025-09-30	$881,035	60,180	-11.4%	Shares	Sole	2025-11-06
2025-06-30	$1,049,734	67,900	-3.9%	Shares	Sole	2025-08-12
2025-03-31	$1,050,297	70,632	-5.2%	Shares	Sole	2025-05-29
2024-12-31	$986,869	74,537	+0.3%	Shares	Sole	2025-05-29
2024-09-30	$1,057,242	74,349	0.0%	Shares	Sole	2024-11-12
2024-06-30	$962,076	74,349	+9.3%	Shares	Sole	2024-08-01
2024-03-31	$945,158	68,046	+18.1%	Shares	Sole	2024-05-09
2023-12-31	$822,323	57,626	-0.5%	Shares	Sole	2024-02-08
2023-09-30	$895,573	57,891	+1.0%	Shares	Sole	2023-11-09
2023-06-30	$900,434	57,316	+281.2%	Shares	Sole	2023-08-08
2020-12-31	$273,655	15,036	+33.5%	Shares	Sole	2021-02-10
2020-09-30	$200,985	11,266	—	Shares	Sole	2020-11-12
No filing history on record for this holder in this stock.